ONCY
Oncolytics Biotech
ONCY
ONCY
50 hedge funds and large institutions have $750K invested in Oncolytics Biotech in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
38% less capital invested
Capital invested by funds: $1.21M → $750K (-$456K)
Holders
50
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$27.8K | |
| 2 | +$22K | |
| 3 | +$16.7K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$8.34K |
Top Sellers
| 1 | -$90K | |
| 2 | -$32.9K | |
| 3 | -$7.13K | |
| 4 |
Morgan Stanley
New York
|
-$3.02K |
| 5 |
BHWM
Beaird Harris Wealth Management
Dallas,
Texas
|
-$754 |
